- Q1 2024 Cytokinetics Inc Earnings Call TranscriptMay 08, 2024$65.27 (-0.02%)Earnings
- Q4 2023 Cytokinetics Inc Earnings Call TranscriptFeb 27, 2024$80.99 (+2.52%)Earnings
- Cytokinetics Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Cytokinetics Inc to Discuss the Topline Results from SEQUOIA-HCM TranscriptDec 27, 2023
- Cytokinetics Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Cytokinetics Inc Earnings Call TranscriptNov 02, 2023$34.64 (-1.31%)Earnings
- Cytokinetics Inc To Host Virtual Investor & Analyst Day TranscriptOct 19, 2023
- Cytokinetics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Cytokinetics Inc Earnings Call TranscriptAug 03, 2023$31.7 (+1.99%)Earnings
- Cytokinetics Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Cytokinetics Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Cytokinetics Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 10, 2023
- Q1 2023 Cytokinetics Inc Earnings Call TranscriptMay 04, 2023$39.29 (-0.13%)Earnings
- Cytokinetics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Cytokinetics Inc To Discuss COURAGE-ALS Update Call TranscriptMar 31, 2023
- Cytokinetics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Cytokinetics Inc ACC.23 Conference Call TranscriptMar 06, 2023
- Q4 2022 Cytokinetics Inc Earnings Call TranscriptMar 01, 2023$43.11 (-0.58%)Earnings
- Cytokinetics Inc To Discuss Omecamtiv Mecarbil Regulatory Update Call TranscriptMar 01, 2023
- Cytokinetics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Cytokinetics Inc FDA Advisory Committee for Omecamtiv Mecarbill Update Call TranscriptDec 14, 2022
- Q3 2022 Cytokinetics Inc Earnings Call TranscriptNov 03, 2022$39.75 (-5.06%)Earnings
- Cytokinetics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Cytokinetics Inc Earnings Call TranscriptAug 04, 2022$46.72 (+9.06%)Earnings
- Cytokinetics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2022
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 10, 2022
- Q1 2022 Cytokinetics Inc Earnings Call TranscriptMay 04, 2022$41.03 (+2.58%)Earnings
- Cytokinetics Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- Q4 2021 Cytokinetics Inc Earnings Call TranscriptFeb 24, 2022$33.95 (+8.29%)Earnings
- Cytokinetics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Cytokinetics Inc and Royalty Pharma Funding Agreements Call TranscriptJan 07, 2022
- Cytokinetics Inc and Ji Xing Pharmaceuticals Ltd Call to Discuss Announced Expansion of Collaboration TranscriptDec 20, 2021
- Q3 2021 Cytokinetics Inc Earnings Call TranscriptNov 03, 2021$36.67 (+5.74%)Earnings
- Cytokinetics Inc Analyst and Investor Day TranscriptOct 07, 2021
- Cytokinetics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Cytokinetics Inc Call to Discuss the Full Results from REDWOOD-HCM TranscriptSep 13, 2021
- Q2 2021 Cytokinetics Inc Earnings Call TranscriptAug 05, 2021$30.24 (+2.47%)Earnings
- Cytokinetics Inc to Discuss Positive Topline Results of Redwood-HCM Call TranscriptJul 19, 2021
- Cytokinetics Inc at Raymond James Human Health Innovation Conference (Virtual) TranscriptJun 21, 2021
- Cytokinetics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 12, 2021
- Q1 2021 Cytokinetics Inc Earnings Call TranscriptMay 06, 2021$23.37 (-0.89%)Earnings
- Cytokinetics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Q4 2020 Cytokinetics Inc Earnings Call TranscriptFeb 25, 2021$19.85 (-4.34%)Earnings
- Cytokinetics Inc Investor Event TranscriptNov 23, 2020
- Cytokinetics Inc GALACTIC-HF Investor/Media Event TranscriptNov 13, 2020
- Q3 2020 Cytokinetics Inc Earnings Call TranscriptNov 04, 2020$18 (+7.66%)Earnings
- Cytokinetics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 Cytokinetics Inc Earnings Call TranscriptAug 06, 2020$21.64 (-2.21%)Earnings
- Cytokinetics Inc Virtual Analyst & Investor Day TranscriptJul 15, 2020
- Cytokinetics Inc Licensing Collaboration And Royalty Monetization Deals With RTW Investments Focused To CK-274 Corporate Call TranscriptJul 14, 2020
- Cytokinetics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 13, 2020
- Q1 2020 Cytokinetics Inc Earnings Call TranscriptMay 06, 2020$16.63 (+1.28%)Earnings
- Q4 2019 Cytokinetics Inc Earnings Call TranscriptMar 03, 2020$14.57 (+2.32%)Earnings
- Q3 2019 Cytokinetics Inc Earnings Call TranscriptOct 31, 2019$11.65 (-1.60%)Earnings
- Cytokinetics Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Cytokinetics Inc Earnings Call TranscriptAug 08, 2019$13.63 (+2.02%)Earnings
- Cytokinetics Inc at JMP Securities Life Science Conference TranscriptJun 19, 2019
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 15, 2019
- Q1 2019 Cytokinetics Inc Earnings Call TranscriptMay 09, 2019$9.01 (+0.78%)Earnings
- Cytokinetics Inc Discusses Results from FORTITUDE-ALS TranscriptMay 06, 2019
- Cytokinetics Inc at Needham Healthcare Conference TranscriptApr 10, 2019
- Cytokinetics Inc at H C Wainwright Global Life Sciences Conference TranscriptApr 08, 2019
- Q4 2018 Cytokinetics Inc Earnings Call TranscriptFeb 21, 2019$7.21 (-1.77%)Earnings
Cytokinetics Inc Analyst and Investor Day Transcript
I'm Joanna Siegall, Senior Manager of Corporate Communications and Investor Relations at Cytokinetics. I'm pleased to welcome you to Charting The Commercial Course, our 2021 Analyst and Investor Day.
We are pleased to be hosting this event in a hybrid fashion, and we welcome everyone here in the room as well as everyone attending online. We have a great program for you today, and we look forward to sharing updates on our go-to-market strategy for omecamtiv as well as our cardiovascular pipeline.
Before I continue, please note that portions of the following discussion, including our responses to questions, contain statements that relate to future events and performance rather than historical facts and constitute forward-looking statements. Our actual results might differ materially from those projected in these forward-looking statements. Additional information concerning factors that could cause our actual results to differ materially from those in these forward-looking statements is contained in our SEC filings. We undertake no obligation to update any forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)